Not Signed In -
Docosahexaenoic Acid (DHA) |
|
|
Clinical Trial: Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
This study is currently recruiting patients.
Verified by Novartis September 2005
|
Purpose
This extension study is designed to assess the long term safety and efficacy of zoledronic acid in postmenopausal women with osteoporosis who have participated in the CZOL446H2301 study (HORIZON Pivotal Fracture Trial).
| Condition | Intervention | Phase |
|---|---|---|
| Osteoporosis | Drug: Zoledronic Acid | Phase III |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Study start: June 2005
Eligibility
Ages Eligible for Study: 65 Years - 93 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Patients who have received 3 infusions in the HORIZON-Pivotal Fracture (PFT) Study.
Exclusion Criteria:
- Poor kidney, eye, or liver health
- Use of certain therapies for osteoporosis in the HORIZON-PFT study (other than the study medication)
- Abnormal calcium levels in the blood
Other protocol-defined inclusion/exclusion criteria may apply.
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00145327
Novartis Pharmaceuticals 862-778-8300
Arizona
Southern Arizona VA, Tucson, Arizona, 85723, United States; Not yet recruiting
Lynda Seal 520-629-4732 Ext. 5059
Arkansas
University of Arkansas for Medical Science, Little Rock, Arkansas, 72205, United States; Not yet recruiting
Beverly Tolliver 501-686-5087
California
Osteoporosis Prevention Center, San Diego, California, 92103, United States; Recruiting
Karen McCrea, RT 619-291-2321
University of California Davis- Gen Medical Research, Sacramento, California, 95817, United States; Not yet recruiting
Ann Koscki 916-734-3219
Osteoporosis Medical Center, Beverly Hills, California, 90211, United States; Not yet recruiting
Carol Joseph, RN 310-358-8350
Diablo Clinical Research, Inc, Walnut Creek, California, 94598, United States; Not yet recruiting
Colleen Kirkland 925-930-7267 Ext. 224
Colorado
Colorado Center for Bone Research, Lakewood, Colorado, 80227, United States; Not yet recruiting
Carol Wasnok, RN 303-980-9985
Florida
Comprehensive Clinical Trials, LLC, West Palm Beach, Florida, 33409, United States; Not yet recruiting
Linda Wyatt 561-478-3177
Radiant Research, Stuart, Florida, 34996, United States; Recruiting
Diane Anderson 772-781-3000 Ext. 221
CRIA Research, Ft. Lauderdale, Florida, 33334, United States; Not yet recruiting
Janet Fitzpatrick 954-229-0425
Georgia
United Osteoporosis Centers (UOC), Gainesville, Georgia, 30501, United States; Recruiting
Lynn Henson 770-534-5154
Illinois
Northwestern University Center for Clinical Research, Chicago, Illinois, 60611, United States; Not yet recruiting
Lucius Robinson 312-503-2312
Indiana
School of Medicine, Indianapolis, Indiana, 46202, United States; Not yet recruiting
Connie Sullivan 317-274-8431
Kansas
Heartland Research Associates, LLC, Wichita, Kansas, 67207, United States; Recruiting
Terri Ford 316-689-6634
Maine
Maine Center for Osteoporosis Research and Education, Bangor, Maine, 04401, United States; Recruiting
Deb Storm 207-262-1176
Maryland
Osteoporosis Clinical Trial Center, Hagerstown, Maryland, 21740, United States; Recruiting
Kathleen Renee, RN 301-791-6680
Massachusetts
Clinical Pharmacology Study Groups, Worcester, Massachusetts, 01610, United States; Recruiting
Mary Coughlin RN 508-752-1824
Missouri
Washington University Center for Clinical Studies, St. Louis, Missouri, 62110, United States; Not yet recruiting
Sherry Banez-Muth, RN 314-454-8023
New Mexico
New Mexico Clinical Research and Osteoporosis Center Inc, Albuquerque, New Mexico, 87106, United States; Recruiting
Valerie White 505-855-5505
New York
Winthrop U Hospital, Mineola, New York, 11501, United States; Not yet recruiting
Jane S Moore RN/BSN, CCRC 516-663-4776
North Dakota
Odyssey Research Services/CCRC Internal Medical, Fargo, North Dakota, 58104, United States; Recruiting
Deb Pilon 701-232-7705
Ohio
University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati, Ohio, 45219, United States; Not yet recruiting
Cindy Powell 513-475-7400 Ext. 7418
Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19131, United States; Not yet recruiting
Elizabeth Grace 215-578-3433
Radiant Research, Wyomissing, Pennsylvania, 19610, United States; Recruiting
Ellie Alderfer 610-374-8291 Ext. 237
University of Pittsburgh, Pittsburgh, Pennsylvania, 15261, United States; Not yet recruiting
Linda Prebehalla 412-383-2428
Rhode Island
Rhode Island Hospital, Endocrinology Clinical Research Unit, Providence, Rhode Island, 02903, United States; Not yet recruiting
Kim Conklin 401-444-2091
Tennessee
University of Tennessee Health Science, Memphis, Tennessee, 38105, United States; Not yet recruiting
Page Igou, CCRC 901-347-8411
Virginia
VA Commonwealth University, Richmond, Virginia, 23298, United States; Not yet recruiting
Marian Sheppard BSN, CCRC 804-828-8932
Washington
Puget Sound Osteoporosis Center, Seattle, Washington, 98144, United States; Not yet recruiting
Judy Lore 206-621-4389
More Information
Study ID Numbers: CZOL446H2301E1
Last Updated: September 2, 2005
Record first received: September 1, 2005
ClinicalTrials.gov Identifier: NCT00145327
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-06
Last Updated: September 2, 2005
Record first received: September 1, 2005
ClinicalTrials.gov Identifier: NCT00145327
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-06
email this page
print this page
bookmark this page
feedback on this page
